SIRT2 and non-small cell lung carcinoma: This finding provides the mechanistic framework by which AKR1C1 acetylation promotes the metastasis of NSCLC cells, and represents SIRT2 as a down-regulator of NSCLC metastasis through the deacetylation of AKR1C1.